
Treating Parkinson's disease with magnetic stimulation
rTMS for Parkinson's disease
What the treatment targets:
In an , magnetic stimulation improved the motor symptoms of patients with Parkinson's disease. The best evidence is for high-frequency stimulation of the motor cortex on both sides, and it is also listed in the . This is exactly the approach we offer, as an outpatient treatment alongside your existing therapy.
Go to the contact form
How it works
How magnetic stimulation works in Parkinson's disease
Magnetic stimulation has been studied in controlled trials for more than two decades, and there are more than 100 studies in Parkinson's disease.
Process
How your treatment works
Non-invasive
No surgery, no anaesthesia
Complementary
Your medication stays the same
About 30 minutes
Per session
Medically led
Indication, threshold and follow-up
Medical leadership
Dr. Tim Schwarz
Dr. Tim Schwarz führt die Behandlung mit medizinischer Sorgfalt und persönlicher Begleitung der Patientinnen und Patienten.

Clinical expertise
Trained at:


Experience gained at the practice of his father, Dr. Schwarz in Ulm - specialised in non-invasive brain stimulation for many years.
Personally there for you
- No referral needed
- Discreet, empathetic consultation
- Clear information on costs and options - before treatment begins
Contact
Get more information
Free of charge by email. We will get back to you without obligation.
Suitability is assessed by a doctor in each individual case. The treatments are self-pay services; private health insurers often reimburse them.
Frequently asked questions
Your questions about rTMS for Parkinson's disease
Anything not answered here we discuss in the free initial consultation.
Research
What the research shows
There are more than 100 studies on magnetic stimulation in Parkinson's disease. Here are three of them.
The European guideline on the therapeutic use of magnetic stimulation (Lefaucheur et al. 2020, Clinical Neurophysiology) lists high-frequency stimulation of the motor cortex on both sides for motor symptoms in Parkinson's disease at evidence level B. The device we use is intended for the treatment of depression, so for Parkinson's disease treatment is given as an individual treatment attempt.

